Our top pick for
Venus Concept Inc is a medical devices business based in the US. Venus Concept shares (VERO) are listed on the NASDAQ and all prices are listed in US Dollars. Venus Concept employs 525 staff and has a trailing 12-month revenue of around USD$84 million.
Since the stock market crash in March caused by coronavirus, Venus Concept's share price has had significant negative movement.
Its last market close was USD$2.07, which is 74.69% down on its pre-crash value of USD$8.18 and 0.49% up on the lowest point reached during the March crash when the shares fell as low as USD$2.06.
If you had bought USD$1,000 worth of Venus Concept shares at the start of February 2020, those shares would have been worth USD$375.56 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$308.49.
|Latest market close||USD$2.07|
|52-week range||USD$2.01 - USD$8.875|
|50-day moving average||USD$2.3217|
|200-day moving average||USD$2.8539|
|Wall St. target price||USD$6.15|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-9.6346|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-19)||N/A|
|1 month (2020-10-30)||-1.90%|
|3 months (2020-08-26)||N/A|
|6 months (2020-05-26)||N/A|
|1 year (2019-11-26)||N/A|
|2 years (2018-11-26)||N/A|
|3 years (2017-11-26)||N/A|
|5 years (2015-11-26)||N/A|
|Revenue TTM||USD$84 million|
|Gross profit TTM||USD$76.7 million|
|Return on assets TTM||-14.53%|
|Return on equity TTM||-326.17%|
|Market capitalisation||USD$97.5 million|
TTM: trailing 12 months
There are currently 260,526 Venus Concept shares held short by investors – that's known as Venus Concept's "short interest". This figure is 15.4% down from 308,109 last month.
There are a few different ways that this level of interest in shorting Venus Concept shares can be evaluated.
Venus Concept's "short interest ratio" (SIR) is the quantity of Venus Concept shares currently shorted divided by the average quantity of Venus Concept shares traded daily (recently around 53168.571428571). Venus Concept's SIR currently stands at 4.9. In other words for every 100,000 Venus Concept shares traded daily on the market, roughly 4900 shares are currently held short.
However Venus Concept's short interest can also be evaluated against the total number of Venus Concept shares, or, against the total number of tradable Venus Concept shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Venus Concept's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Venus Concept shares in existence, roughly 10 shares are currently held short) or 0.0126% of the tradable shares (for every 100,000 tradable Venus Concept shares, roughly 13 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Venus Concept.
Find out more about how you can short Venus Concept stock.
We're not expecting Venus Concept to pay a dividend over the next 12 months.
Venus Concept's shares were split on a 1:15 basis on 8 November 2019. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Venus Concept shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Venus Concept shares which in turn could have impacted Venus Concept's share price.
Venus Concept Inc. operates as a medical aesthetic technology company worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-treatment platform to address the aesthetic procedures without surgery or downtime; Venus Legacy, an advanced device that resolves challenging face and body aesthetic needs; Venus Velocity, a diode laser for hair removal; Venus Fiore, which addresses internal vaginal health restoration, labia skin tightening, and mons pubis reduction; Venus Viva, a customizable skin resurfacing device that allows operator control of ablation and coagulation for resolving the appearance of mild to severe skin damage for various skin types; Venus Freeze Plus, an anti-aging system for non-invasive skin tightening; and Venus Bliss, a solution for the fat reduction category. The company also offers NeoGraft, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process; and ARTAS and ARTAS iX robotic hair restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept Inc. is headquartered in Toronto, Canada.
Everything we know about the Qilian International Holding Group IPO, plus information on how to buy in.
Everything we know about the AbCellera Biologics IPO, plus information on how to buy in.
Steps to owning and managing CALM, with 24-hour and historical pricing before you buy.
Steps to owning and managing CRR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BG, with 24-hour and historical pricing before you buy.
Steps to owning and managing BCLI, with 24-hour and historical pricing before you buy.
Steps to owning and managing BLBD, with 24-hour and historical pricing before you buy.
Steps to owning and managing BDTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing RILYO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASPN, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.